Gene · 8835
Papers2,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2024 | 38957436 | PubTator, text mining | PubMed |
| The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response. | Helicobacter | 2024 | 38924222 | PubTator, text mining | PubMed |
| Characterization of alternative splicing events and prognostic signatures in gastric cancer. | Cancer Cell Int | 2024 | 38734676 | PubTator, text mining | PubMed |
| Desflurane alleviates LPS-induced acute lung injury by modulating let-7b-5p/HOXA9 axis. | Immunol Res | 2024 | 38676899 | PubTator, text mining | PubMed |
| A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma. | BMC Med Genomics | 2024 | 38627714 | PubTator, text mining | PubMed |
| Ribonucleic Acid Sequencing Reveals the Upregulation and Resolution of Inflammation and Extracellular Matrix Remodeling in Lidocaine-Treated Human Acute Monocytic Leukemia Cell Line THP-1. | Biomedicines | 2024 | 38540122 | PubTator, text mining | PubMed |
| Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma. | Cancer Cell Int | 2024 | 38528605 | PubTator, text mining | PubMed |
| Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma. | PeerJ | 2024 | 38515461 | PubTator, text mining | PubMed |
| ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion. | Cell Rep | 2024 | 38363677 | PubTator, text mining | PubMed |
| Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies. | Chin Med | 2024 | 38310315 | PubTator, text mining | PubMed |
| What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade? | World J Clin Oncol | 2024 | 38292666 | PubTator, text mining | PubMed |
| Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance. | Exp Hematol Oncol | 2024 | 38291542 | PubTator, text mining | PubMed |
| Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | 38282696 | PubTator, text mining | PubMed |
| m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway. | J Transl Med | 2024 | 38281945 | PubTator, text mining | PubMed |
| JAK/STAT in leukemia: a clinical update. | Mol Cancer | 2024 | 38273387 | PubTator, text mining | PubMed |
| POU6F1 promotes ferroptosis by increasing lncRNA-CASC2 transcription to regulate SOCS2/SLC7A11 signaling in gastric cancer. | Cell Biol Toxicol | 2024 | 38267746 | PubTator, text mining | PubMed |
| Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer. | PeerJ | 2024 | 38259671 | PubTator, text mining | PubMed |
| Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. | Int J Mol Sci | 2024 | 38255942 | PubTator, text mining | PubMed |
| Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities. | Int J Mol Sci | 2024 | 38255828 | PubTator, text mining | PubMed |
| Persistence of microbiological hazards in food and feed production and processing environments. | EFSA J | 2024 | 38250499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8835/papers?page=6